Table 1.
Mouse | Age at Death | Gross phenotype | Surface expression |
---|---|---|---|
8 | 94 | thymic lymphoma | n.d. |
95 | 138 | thymic lymphoma | n.d. |
106 | 92 | thymic lymphoma | TCRβ− DP/CD8+ |
211 | 98 | disseminated disease | TCRβ− DP |
213 | 121 | thymic lymphoma | TCRβ− CD8+ |
215 | 77 | thymic lymphoma | TCRβ− DP/CD8+ |
232 | 137 | thymic lymphoma | TCRβ− DP |
242 | 114 | thymic lymphoma | TCRβ− CD8+ |
277 | 115 | thymic lymphoma | TCRβ− CD8+ |
282 | 119 | thymic lymphoma | TCRβint DP |
292 | 101 | thymic lymphoma | TCRβint DP/CD8+ |
321 | 97 | thymic lymphoma | TCRβ− DP |
445 | 172 | thymic lymphoma | TCRβ− DP/CD8+ |
447 | 130 | thymic lymphoma | TCRβ− CD8+ |
538 | 85 | thymic lymphoma | n.d. |
557 | 74 | thymic lymphoma | TCRβ− DP |
608 | 194 | thymic lymphoma | TCRβ− CD8+ |
611 | 294 | thymic lymphoma | TCRβ− DP/CD8+ |
612 | 180 | thymic lymphoma | TCRβint DP/CD8+ |
646 | 97 | thymic lymphoma | TCRβ− DP/CD8+ |
673 | 90 | thymic lymphoma | TCRβ− CD4/8 var |
715 | 83 | thymic lymphoma | TCRβ− DP |
751 | 276 | thymic lymphoma | n.d. |
752 | 152 | thymic lymphoma | TCRβ− DP/CD8+ |
771 | 121 | thymic lymphoma | n.d. |
938 | 128 | thymic lymphoma | n.d. |